Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ENANTA PHARMACEUTICALS INC | Chief Business Officer | Common Stock | 39.1K | $485K | $12.41 | Feb 12, 2024 | Direct |
ENANTA PHARMACEUTICALS INC | Chief Business Officer | Stock Option (right to buy) | 83K | Nov 22, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENTA | ENANTA PHARMACEUTICALS INC | Feb 12, 2024 | 2 | -$12.1K | 4 | Feb 14, 2024 | Chief Business Officer |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 5, 2023 | 1 | -$20.5K | 4 | Dec 6, 2023 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2023 | 1 | -$7.15K | 4 | Dec 5, 2023 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 22, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Feb 13, 2023 | 3 | -$339K | 4 | Feb 15, 2023 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2022 | 1 | -$22.1K | 4 | Dec 5, 2022 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 23, 2022 | 2 | $0 | 4 | Nov 28, 2022 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Feb 14, 2022 | 3 | -$30.6K | 4 | Feb 15, 2022 | Sr. VP, Business Dev. |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 19, 2021 | 2 | $0 | 4 | Nov 23, 2021 | Sr. VP, Business Dev. |